← Leaderboards
Clark Chin-Chung Chen
University Of California, San Diego
$2,791,055
Attributed
$4,995,663
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2016–22$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,995,663 · 3
By mechanism
R01$3,495,749 · 2
R44$1,499,914 · 1
Top collaborators
- Wei Chen4 shared
- Zhi-Pei Liang4 shared
- Yu-Hwa Lo2 shared
- Jose Manuel Morachis2 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- George L Sen$13,431,495
- Terence Hwa$10,914,599
- Peter John Davidson$7,709,517
- Edward A Dennis$23,868,823
- Tommi Lynn Gaines$4,336,355
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelGlioblastomaCellsInnovationBaseResistanceEngineeringCaringBrain NeoplasmsSpecimenTumorAdultMalignant Neoplasm Of BrainOperative Surgical ProceduresIn VivoLaboratoriesCollaborationsCell LineNeurosurgeonDiagnosisCancer CellComputer SoftwareImageChemotherapy
Grant awards (11)
Development of Quantitative Deuterium MRS Imaging for Human Brain Tumor Application at Ultrahigh Field$529,985
R01 · FY2022 · CA
Targeting Mechanisms of Acquired Temozolomide Resistance in Glioblastoma$336,875
R01 · FY2021 · NS · contact PI
Development of Quantitative Deuterium MRS Imaging for Human Brain Tumor Application at Ultrahigh Field$179,567
R01 · FY2021 · CA
Development of Quantitative Deuterium MRS Imaging for Human Brain Tumor Application at Ultrahigh Field$559,810
R01 · FY2020 · CA
Targeting Mechanisms of Acquired Temozolomide Resistance in Glioblastoma$336,875
R01 · FY2020 · NS · contact PI
Development of Quantitative Deuterium MRS Imaging for Human Brain Tumor Application at Ultrahigh Field$537,636
R01 · FY2019 · CA
Targeting Mechanisms of Acquired Temozolomide Resistance in Glioblastoma$336,875
R01 · FY2019 · NS · contact PI
High-throughput single-cell sorting and kinetic analysis of secreted particles$749,957
R44 · FY2018 · GM
High-throughput single-cell sorting and kinetic analysis of secreted particles$749,957
R44 · FY2017 · GM
Targeting Mechanisms of Acquired Temozolomide Resistance in Glioblastoma$339,063
R01 · FY2017 · NS · contact PI
Targeting Mechanisms of Acquired Temozolomide Resistance in Glioblastoma$339,063
R01 · FY2016 · NS · contact PI